Press Releases Items Per Page 102550 Year None20222021202020192018201720162015201420132012201120102007 08.08.22 Syndax Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Clinical and Business Update 08.02.22 Syndax to Announce Second Quarter 2022 Financial Results and Host Conference Call and Webcast on August 8, 2022 06.16.22 Syndax Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 06.13.22 Syndax Pharmaceuticals Announces Appointment of Keith A. Goldan as Chief Financial Officer 05.26.22 Syndax Announces Participation at Two Upcoming Investor Conferences 05.11.22 Syndax Announces Participation at Citi's Biopharma Virtual Co-Panel Day 05.09.22 Syndax Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Clinical and Business Update 05.02.22 Syndax to Announce First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 9, 2022 03.04.22 Syndax Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 03.01.22 Syndax Pharmaceuticals Reports Fourth Quarter 2021 Financial Results and Provides Clinical and Business Update 03.01.22 Syndax Pharmaceuticals Announces Appointment of Kate Madigan, M.D., as Chief Medical Officer 02.28.22 Syndax Announces Participation at Two Upcoming Investor Conferences Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
08.08.22 Syndax Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Clinical and Business Update
08.02.22 Syndax to Announce Second Quarter 2022 Financial Results and Host Conference Call and Webcast on August 8, 2022
05.09.22 Syndax Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Clinical and Business Update
05.02.22 Syndax to Announce First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 9, 2022
03.01.22 Syndax Pharmaceuticals Reports Fourth Quarter 2021 Financial Results and Provides Clinical and Business Update
03.01.22 Syndax Pharmaceuticals Announces Appointment of Kate Madigan, M.D., as Chief Medical Officer
